BNP Paribas Financial Markets’s BioNTech BNTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123M	Sell	1,319,517 -332,272	-20%	-$31.3M	0.04%	378
2026 Q1	$147M	Buy	1,651,789 +73,695	+5%	+$7.57M	0.07%	282
2025 Q4	$150M	Buy	1,578,094 +474,796	+43%	+$47.8M	0.07%	270
2025 Q3	$109M	Sell	1,103,298 -172,177	-13%	-$18.4M	0.06%	335
2025 Q2	$136M	Buy	1,275,475 +80,005	+7%	+$8.08M	0.08%	231
2025 Q1	$109M	Buy	1,195,470 +581,173	+95%	+$65.1M	0.06%	321
2024 Q4	$70M	Buy	+614,297	New	+$70.1M	0.04%	478
2024 Q1	–	Sell	-231	Closed	-$24.4K	–	4059
2023 Q4	$24.4K	Buy	+231	New	+$23.3K	﹤0.01%	3648

Other funds holding BNTX

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

GSK plc London $602M AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

DCP

Davern Capital Partners Ny, New York $587M AUM

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BNP Paribas Financial Markets's BNTX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its BioNTech (BNTX) stake by 20% in Q2 2026, selling an estimated $31.3M and leaving 1,319,517 shares worth $123M. The position accounts for 0.04% of the portfolio, ranked #378.

BNP Paribas Financial Markets first reported a position in BNTX in Q4 2023 and has held it in 8 quarters since. The position peaked at $150M in Q4 2025. 199 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

BNP Paribas Financial Markets held 1,319,517 shares of BioNTech worth $123M as of Q2 2026.
BNP Paribas Financial Markets sold 332,272 BioNTech shares in Q2 2026, an estimated $31.3M.
BioNTech made up 0.04% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #378 holding.
BNP Paribas Financial Markets first reported a position in BioNTech in Q4 2023 and has held it in 8 quarters since.
BNP Paribas Financial Markets's BioNTech position peaked at $150M in Q4 2025.
199 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.